Skip to content

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform:
Publications

man working - Alto publications hero

Leveraging clinical and biological insights to drive innovation in psychiatry

See our publications, presentations, and more to discover the revolutionary potential of our precision approach.

Choose Resource Type
Choose Focus Area
Search Resources

Found 57 Results

April 28, 2025

Prospective Replication and Application of an EEG-based Placebo Response Prediction Biomarker in Randomized Controlled Trials in Depression

April 3, 2025

ALTO-101 Modulates EEG Biomarkers Linked to Cognitive Impairment in Schizophrenia: Evidence from a Phase 1 Trial and BSNIP Studies

February 24, 2025

Standardization of EEG Enrichment Marker Acquisitions in a Randomized, Double-Blind, Placebo-Controlled Study of ALTO-300 in Adults with Major Depressive Disorders

December 12, 2024

Prevalence and Correlates of Cognitive Impairment in Depression: Findings from the Texas Resilience Against Depression Study

December 12, 2024

Neural and Molecular Mechanistic Correlates of an EEG Biomarker Predictive of the Antidepressant Response to ALTO-300 in Patients with Major Depression

December 12, 2024

Validation of Assessments for Reward Processing for Use in a Phase 2 Study of a Novel Histamine H3 Inverse Agonist, ALTO-203, in Major Depression

September 21, 2024

Effects of ALTO-203 on Positive Emotion and Reward Processing: Methods and Supporting Data for an Ongoing Phase 2 Proof-of-concept Study

«123 4 5...»

650 Castro Street, Suite 450
Mountain View, CA 94041

Company

About
Leadership
Careers
Contact

Science

Platform
Publications
Pipeline

Investors

Overview
News
Events & Presentations
Stock Info
SEC Filings
Corporate Governance
Resources

Privacy Policy
Terms of Use
Accessibility
Cookie Policy

© 2025 Alto Neuroscience Inc. All rights reserved.

Scroll to Top